Nanexa AB - Asset Resilience Ratio

Latest as of March 2026: 40.01%

Nanexa AB (NANEXA) has an Asset Resilience Ratio of 40.01% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Skr66.69 Million

≈ $7.18 Million USD Cash + Short-term Investments

Total Assets

Skr166.70 Million

≈ $17.94 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2020–2025)

This chart shows how Nanexa AB's Asset Resilience Ratio has changed over time. Check strategic asset allocation of Nanexa AB to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Nanexa AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Nanexa AB.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr0.00	0%
Short-term Investments	Skr66.69 Million	40.01%
Total Liquid Assets	Skr66.69 Million	40.01%

Asset Resilience Insights

Very High Liquidity: Nanexa AB maintains exceptional liquid asset reserves at 40.01% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Nanexa AB Industry Peers by Asset Resilience Ratio

Compare Nanexa AB's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Beijing Sun Novo Pharmaceutical Research Co Ltd SHG:688621	Drug Manufacturers - Specialty & Generic	2.04%
Guizhou Xinbang Pharmaceutical Co Ltd SHE:002390	Drug Manufacturers - Specialty & Generic	0.01%
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	Drug Manufacturers - Specialty & Generic	7.85%
Jw Pharmac KO:001060	Drug Manufacturers - Specialty & Generic	3.65%
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Samjin Pharm KO:005500	Drug Manufacturers - Specialty & Generic	0.25%

Annual Asset Resilience Ratio for Nanexa AB (2020–2025)

The table below shows the annual Asset Resilience Ratio data for Nanexa AB.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	26.35%	Skr36.40 Million ≈ $3.92 Million	Skr138.14 Million ≈ $14.87 Million	-11.46pp
2023-12-31	37.81%	Skr50.00 Million ≈ $5.38 Million	Skr132.26 Million ≈ $14.23 Million	+37.81pp
2022-12-31	0.00%	Skr-1.00K ≈ $-107.62	Skr170.19 Million ≈ $18.32 Million	+0.02pp
2021-12-31	-0.02%	Skr-31.00K ≈ $-3.34K	Skr165.00 Million ≈ $17.76 Million	+0.17pp
2020-12-31	-0.19%	Skr-100.00K ≈ $-10.76K	Skr53.69 Million ≈ $5.78 Million	--

pp = percentage points

About Nanexa AB

ST:NANEXA Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$82.83 Million

Skr769.64 Million SEK

Market Cap Rank

#19821 Global

#351 in Sweden

Share Price

Skr4.17

Change (1 day)

-2.80%

52-Week Range

Skr1.61 - Skr4.92

All Time High

Skr15.20